epiTCRTM 

epiTCRTM is our inhouse proprietary multi-feature algorithm that was built using comprehensive own data including tumor bank (300 patients), Co-IP and MS/MS (9,000 HLA bound

peptides), validated patient data. epiTCRTM increases the accuracy of prediction up to 20% compared to others.

SCIENTIFIC PROBES:
1 publication

1 patent filed to USPTO